CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients

OBJECTIVE: Chaperonin‐containing tailless complex polypeptide subunit 6A (CCT6A) is a critical regulator and newly identified clinical biomarker of several cancers, while its correlation with the clinical characteristics and prognosis of cervical cancer patients is unclear. Therefore, this study aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jiancai, Yang, Liping, Feng, Haiqin, Zheng, Lulu, Meng, Huifang, Li, Xuefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373327/
https://www.ncbi.nlm.nih.gov/pubmed/34196992
http://dx.doi.org/10.1002/jcla.23793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373327/
https://www.ncbi.nlm.nih.gov/pubmed/34196992
http://dx.doi.org/10.1002/jcla.23793

Ejemplares similares